Special Drug Use Investigation for AMERGE Tablet.

Trial Profile

Special Drug Use Investigation for AMERGE Tablet.

Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Naratriptan (Primary)
  • Indications Migraine
  • Focus Adverse reactions
  • Acronyms AMERGE
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 01 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Jan 2013 Planned End Date changed from 1 Feb 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.
    • 03 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top